Evidence map›Paper›PMID 35896585›Full record

ArticleScientific reports2022

Descriptive epidemiology of soft tissue sarcomas and gastrointestinal stromal tumors in Thailand.

Jeerawan Klangjorhor, Donsuk Pongnikorn, Pattaralawan Sittiju, Areerak Phanphaisarn, Parunya Chaiyawat, Pimpisa Teeyakasem, Patiwat Kongdang, Sutpirat Moonmuang, Narate Waisri, Karnchana Daoprasert and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jeerawan KlangjorhorMusculoskeletal Science and Translational Research (MSTR) Center, Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Donsuk PongnikornCancer Registry Unit, Lampang Cancer Hospital, Lampang, Thailand.
Pattaralawan SittijuThailand Excellence Center for Tissue Engineering and Stem Cells, Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Areerak PhanphaisarnMusculoskeletal Science and Translational Research (MSTR) Center, Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Parunya ChaiyawatMusculoskeletal Science and Translational Research (MSTR) Center, Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Pimpisa TeeyakasemMusculoskeletal Science and Translational Research (MSTR) Center, Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Patiwat KongdangMusculoskeletal Science and Translational Research (MSTR) Center, Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Sutpirat MoonmuangCenter of Multidisciplinary Technology for Advanced Medicine (CMUTEAM), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Narate WaisriChiang Mai Cancer Registry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Karnchana DaoprasertCancer Registry Unit, Lampang Cancer Hospital, Lampang, Thailand.
Taweechok WisanuyotinDepartment of Orthopaedic, Faculty of Medicine, Khon Kaen University, Khon Kean, Thailand.
Chalongpon SantongCancer Unit, Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Khon Kean, Thailand.
Siriphon SitthikongCancer Registry Unit, National Cancer Institute, Bangkok, Thailand.
Pakjai TuntarattanapongDepartment of Orthopaedic, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
Paradee PrechawittayakulCancer Information Center, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
Dumnoensun PruksakornMusculoskeletal Science and Translational Research (MSTR) Center, Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. dumnoensun.p@cmu.ac.th.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to analyze burden of STS and GIST in population and survival rate which represented the current situation of treatment in Thailand. The data was collected from five population-based cancer registries around the country for the period 2001 through 2015. The Segi world standard population was used to calculated age-standardized incidence rates (ASR). Standardized rate ratios (SRR) were used to compare populations. Joinpoint Trend Analysis was used to assess changes in incidence. STATA was used to examine patient survival rates. During the study period, 4080 cases of STS and 457 cases of GIST were reported. The ASR of STS and GIST was 2.14/100,000 person-years and 0.22/100,000 person-years, respectively. The most common histological types of STS were unspecified sarcoma (24.8%), leiomyosarcoma (19.0%) and liposarcoma (11.4%). The overall ASR of STS in Thailand was relatively low compared to Western countries. The five-year survival rate was 62.6% for STS and 63.4% for GIST, which was comparable to the rates reported in other countries. This is the first report of STS and GIST from PBCRs in Thailand. Based on current healthcare service, an overall survival rates of STS and GIST are comparable to those reported from others.

Indexed as

Gastrointestinal Stromal TumorsLiposarcomaSarcomaSoft Tissue NeoplasmsHumansIncidenceThailand

Identifiers

PMID35896585
PMCPMC9329344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.